Selank Made in USA — Third-Party Verified
PX1 Research provides USA-synthesized Selank engineered strictly for high-precision laboratory and in vitro investigation. Every batch undergoes rigorous HPLC and mass spectrometry verification in an ISO 17025 accredited laboratory to guarantee uncompromising chemical purity and lot-to-lot consistency.
Quick answer
PX1 Research provides USA-synthesized Selank engineered strictly for high-precision laboratory and in vitro investigation. Every batch undergoes rigorous HPLC and mass spectrometry verification in an ISO 17025 accredited laboratory to guarantee uncompromising chemical purity and lot-to-lot consistency.
Key takeaways
- [Selank](/research-peptides/selank) is a synthetic heptapeptide derived from the naturally occurring human immunomodulatory peptide tuftsin, modified with a Pro-Gly-Pro C-terminal sequence to enhance enzymatic stability.
- The origin of synthetic peptides plays a critical role in experimental reliability.
- Preclinical studies indicate that [Selank](/research-peptides/selank) modulates central nervous system pathways through indirect allosteric influences on the gamma-aminobutyric acid (GABA) neurotransmitter system.
- Understanding structural and functional distinctions between synthetic regulatory peptides is essential for designing controlled in vitro experiments.
Overview of Selank in Biochemical Research
Selank is a synthetic heptapeptide derived from the naturally occurring human immunomodulatory peptide tuftsin, modified with a Pro-Gly-Pro C-terminal sequence to enhance enzymatic stability. Structurally designated as Thr-Lys-Pro-Arg-Pro-Gly-Pro, Selank has gained significant attention across neurochemical and immunological research domains due to its unique multi-target signaling profile in cellular and animal models.
When investigating regulatory peptides, research laboratories prioritize molecular stability and structural fidelity. Raw sequence integrity determines how effectively the compound interacts with targeted receptor complexes in vitro. Procuring high-purity Selank made in USA ensures that experimental protocols involving neuroreceptor modulation, gene expression arrays, and enzymatic degradation assays remain reproducible across long-term experimental timelines.
USA Synthesis vs. Offshore Sourcing for Research Standards
The origin of synthetic peptides plays a critical role in experimental reliability. Domestic solid-phase peptide synthesis (SPPS) conducted within cGMP-compliant facilities minimizes the risks of structural isomerism, incomplete peptide sequence assembly, and heavy metal contamination. Offshore sourcing frequently introduces batch variability, trace solvent residues, and undisclosed salt forms that alter molecular weight calculations during molar solution preparation.
PX1 Research synthesizes all peptide inventory within domestic USA facilities adhering to strict quality controls. By maintaining domestic manufacturing chains, laboratories gain transparent access to comprehensive analytical documentation, eliminating uncertainties regarding supply chain handling, ambient temperature degradation during international transit, and regulatory non-compliance. Investigators seeking broader comparative data can explore our research peptides catalog for fully verified reference compounds.
Mechanisms of Action: Neurochemical and Neurotrophic Pathways
Preclinical studies indicate that Selank modulates central nervous system pathways through indirect allosteric influences on the gamma-aminobutyric acid (GABA) neurotransmitter system. In vitro binding assays demonstrate that Selank does not directly bind to primary GABA-A receptor binding sites; rather, it modulates receptor affinity and expression kinetics for endogenous GABA, altering chloride channel opening frequency in neuronal cell cultures.
In addition to GABAergic interaction, rodent models show that Selank administration upregulates the expression of Brain-Derived Neurotrophic Factor (BDNF) and its primary tyrosine kinase receptor, TrkB, within hippocampal tissues. This neurotrophic modulation suggests potential pathways for investigating synaptic plasticity, neuroprotection against oxidative stress, and dendritic arborization. Researchers evaluating central peptide signaling pathways often compare these findings with data from related regulatory peptides in our nootropic research peptides overview.
Comparative Analysis: Selank, Semax, and Tuftsin Analogs
Understanding structural and functional distinctions between synthetic regulatory peptides is essential for designing controlled in vitro experiments. Selank shares structural lineage with tuftsin (Thr-Lys-Pro-Arg), retaining immunomodulatory properties while gaining central stability via its C-terminal tripeptide extension. Conversely, Semax—an ACTH(4-10) analog—acts primarily through melanocortin receptor activation and neurotrophic factor elevation without the direct GABAergic involvement observed with Selank.
In laboratory models evaluating enzymatic stability and metabolic half-life, modified derivatives such as N-Acetyl Semax Amidate and Semax made in USA demonstrate altered resistance to aminopeptidase breakdown compared to native Selank. While Semax research frequently focuses on ischemic neuroprotective cascades and vascular signaling, Selank research concentrates on monoamine balance, enkephalin stabilization, and immunomodulatory gene expression profiles.
Immunomodulatory Signalling and Enkephalin Degradation
Beyond its neurochemical profile, Selank exhibits distinct immunomodulatory pathways in preclinical models. In vitro studies using human peripheral blood mononuclear cells (PBMCs) show that Selank alters the transcript levels of inflammatory cytokines, including IL-6, TNF-alpha, and IL-10, depending on the baseline inflammatory state of the cellular culture.
Furthermore, biochemical assays reveal that Selank acts as a competitive inhibitor of enkephalin-degrading enzymes, such as carboxypeptidase N and neutral endopeptidase. By suppressing the enzymatic cleavage of endogenous Met-enkephalin and Leu-enkephalin, Selank prolongs opioid peptide activity in extracellular tissue culture media, providing a compelling model for studying endogenous peptide stability and cellular stress responses.
Analytical Verification: HPLC, Mass Spectrometry, and Endotoxin Limits
To ensure precise molar concentration calculations in cellular assays, researchers require absolute structural validation. Every lot of USA-synthesized Selank supplied by PX1 Research undergoes rigorous testing in an ISO 17025 accredited analytical facility. High-Performance Liquid Chromatography (HPLC) verifies chemical purity levels exceeding 99%, ensuring the absence of truncated peptide fragments or sequence deletions.
Mass Spectrometry (MS) confirms exact molecular weight (851.96 g/mol for the free base sequence), validating correct amino acid assembly. Additionally, kinetic chromogenic LAL assays confirm that endotoxin levels remain below 0.01 EU/mg, well within strict parameters required for sensitive cell culture assays and in vivo preclinical rodent models. Detailed protocols on analytical verification standards are documented in our guide to peptide purity testing standards.
Laboratory Handling, Reconstitution, and Storage Guidelines
Lyophilized Selank is supplied as a sterile, vacuum-sealed cake or powder. For optimal stability, unopened vials should be stored at -20°C or -80°C in a desiccated environment to prevent moisture absorption. Lyophilized peptides preserved under these conditions maintain chemical integrity for up to 24 months from the synthesis date.
Reconstitution should be performed under aseptic laboratory conditions using sterile bacteriostatic water, phosphate-buffered saline (PBS), or sterile 0.9% sodium chloride solution, depending on experimental design requirements. Once reconstituted, liquid aliquots should be stored at 2°C to 8°C for short-term experimentation or sub-aliquoted and stored at -80°C to prevent degradation from repeated freeze-thaw cycles.
Institutional Procurement and Bulk Lab Accounts
PX1 Research supports academic institutions, biotechnology research organizations, and contract research organizations (CROs) requiring dependable supplies of high-purity research compounds. We offer scalable production volumes, dedicated account support, and customized lot-locking to ensure longitudinal study consistency.
Laboratories seeking bulk quantities or custom synthesis runs can establish an institutional account through our wholesale laboratory portal. Orders are processed with same-day dispatch from our California and Arizona fulfillment centers, ensuring rapid delivery and minimized transit times for temperature-sensitive reagents.
Frequently Asked Questions
What is the certified purity level of PX1 Research Selank made in USA?
PX1 Research guarantees a minimum of 99% purity for every lot of Selank, verified via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) by an independent ISO 17025 accredited laboratory.
How is lot-specific COA documentation provided?
Every unit shipped includes a physical Certificate of Analysis (COA) detailing the exact HPLC chromatogram, mass spectra, and endotoxin assay results for that specific synthesis lot. Digital copies can also be downloaded directly using the lot number.
What are the verified endotoxin levels for Selank?
Our USA-synthesized Selank is tested via kinetic chromogenic LAL assays to ensure endotoxin levels measure strictly below 0.01 EU/mg, preventing cell toxicity or non-specific immune responses in sensitive assays.
What molecular weight should be used for concentration calculations?
The theoretical molecular weight of Selank free base (C37H65N11O10) is approximately 851.96 g/mol. Exact counter-ion adjusted mass is stated on each batch-specific COA for precise molar calculations.
How should reconstituted Selank be stored in a laboratory setting?
After reconstitution in sterile bacteriostatic water or PBS, aliquots should be kept at 2°C to 8°C for up to 14 days. For extended studies, sub-aliquot and store at -80°C to avoid multiple freeze-thaw cycles.
What is the primary structural difference between Selank and Semax?
Selank is a heptapeptide derived from tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro) targeting GABAergic and neurotrophic pathways. Semax is derived from ACTH(4-10) (Met-Glu-His-Phe-Pro-Gly-Pro) targeting melanocortin receptors and vascular signaling pathways.
Does PX1 Research ship temperature-sensitive peptides same day?
Yes. All orders placed before 3 PM EST Monday through Friday ship same-day from our dual distribution hubs in California and Arizona to ensure fast transit and structural preservation.
Are PX1 Research compounds intended for human clinical use?
No. All products offered by PX1 Research, including Selank, are supplied strictly as research chemical compounds for in vitro, laboratory, and preclinical animal investigation only. They are not for human or veterinary use.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.